IL1B and depressive symptom measurement: In this model, depression-like behaviors correlate with the release of pro-inflammatory cytokines, including interleukin 1β (IL1β), interleukin 6 (IL6), and tumor necrosis factor α (TNFα), in both the brain and plasma, thereby establishing a connection between inflammation and depressive symptoms [36,37,38].